New England Journal of Medicine

Journal Abbreviation: NEW ENGL J MED
ISSN: 0028-4793
eISSN: 1533-4406
Publisher: Massachusetts Medical Society

Publications (63)

close-button

Types of publications

Journal article
Unpublished / Preprint

Publication year

From
To

Abstract

In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus (2025) Wang Q, Xiao ZX, Zheng X, Wang G, Yang L, Shi L, Xiang N, et al. Journal article BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease (2025) Bucci L, Böltz S, Hagen M, Tur C, Nöthling DM, Rothe T, Wirsching A, et al. Journal article CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis (2025) Müller F, Atreya R, Völkl S, Aigner M, Kretschmann S, Kharboutli S, Leppkes M, et al. Journal article First-Line Camizestrant for Emerging ESR1 -Mutated Advanced Breast Cancer. (2025) Bidard FC, Mayer EL, Park YH, Janni W, Ma C, Cristofanilli M, Bianchini G, et al. Journal article Intensive Blood-Pressure Control in Patients with Type 2 Diabetes (2025) Schmieder R Journal article Malnutrition in Older Adults (2025) Cruz-Jentoft AJ, Volkert D Journal article, Review article Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes (2025) McGuire DK, Marx N, Mulvagh SL, Deanfield JE, Inzucchi SE, Pop-Busui R, Mann JF, et al. Journal article Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer (2025) Hoeppner J, Brunner T, Schmoor C, Bronsert P, Kulemann B, Claus R, Utzolino S, et al. Journal article Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer (2025) Geyer CE, Untch M, Huang CS, Mano MS, Mamounas EP, Wolmark N, Rastogi P, et al. Journal article Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma. (2025) Wolchok JD, Chiarion-Sileni V, Rutkowski P, Cowey CL, Schadendorf D, Wagstaff J, Queirolo P, et al. Journal article